Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 134

Results For "RNA"

2259 News Found

SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru
Healthcare | October 03, 2022

SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru

This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant


Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences
News | October 03, 2022

Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences

The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.


Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister
Policy | October 01, 2022

Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister

Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India


CAPED Trust and AstraZeneca India launch ‘Ganga Godavari Cancer Screening Program’ in Mathura
Healthcare | September 30, 2022

CAPED Trust and AstraZeneca India launch ‘Ganga Godavari Cancer Screening Program’ in Mathura

In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura


NIHR addresses research in surgery in India
News | September 28, 2022

NIHR addresses research in surgery in India

The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit


There should be no space for fraud in AB-PMJAY: Dr. Mandaviya
Policy | September 27, 2022

There should be no space for fraud in AB-PMJAY: Dr. Mandaviya

The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations


Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age
Drug Approval | September 27, 2022

Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age

The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses


Novartis unveils new focused strategy
News | September 27, 2022

Novartis unveils new focused strategy

Transformation to pure-play Innovative Medicines company nears completion


Puneet Sud appointed additional director of Nectar Lifesciences
People | September 26, 2022

Puneet Sud appointed additional director of Nectar Lifesciences

Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin


Aptar Pharma collaborates with Fluidda
News | September 25, 2022

Aptar Pharma collaborates with Fluidda

The companies will leverage their respective proprietary technology platforms